If You Invested in Investview Inc PFD SER B (INVUP)

INVESTVIEW INC PFD SER B (INVUP) represents a preferred stock series of Investview, Inc., a Nevada corporation that operates a diversified financial technology (FinTech) services business. While INVUP is a preferred equity security, its value and risk profile are closely linked to the operating performance, regulatory environment, and strategic direction of Investview, Inc. as described in the company’s public news releases and SEC filings.

Investview, Inc. is described in multiple disclosures as a diversified financial technology company with several different lines of business. According to its public statements, the company operates a Financial Education and Technology business that delivers products and services involving financial education, digital assets and related technology through a network of independent distributors, including its iGenius business unit. It also operates a Blockchain Technology and Crypto Mining Products and Services segment, often referenced as SAFETek, which focuses on the management of digital asset technologies with an emphasis on Bitcoin mining and related infrastructure.

In addition, Investview reports that it is developing a Brokerage and Financial Markets business. Through the acquisition of Opencash Securities LLC, a registered broker-dealer, and a proprietary trading platform acquired in 2021, the company has disclosed plans to commercialize a modern, mobile-first trading platform for self-directed retail investors, including the Opencash and OpencashPro offerings, subject to regulatory and operational milestones.

Investview also highlights a Manufacturing and Development of Health, Beauty and Wellness Products segment. Through its myLife Wellness subsidiary and the acquisition of Renu Laboratories, Inc. (Renu Labs), the company describes activities in contract development and manufacturing of proprietary and non-proprietary skincare, personal care, hair care, cosmetic, pharmaceutical topical, and wellness products for wholesale and retail clients. myLife Wellness is positioned as the commercial and e-commerce arm for products developed and manufactured by Renu Labs, with distribution through both business-to-consumer and business-to-business channels, and with the potential to be marketed through Investview’s existing global network of independent distributors.

Across these business units, Investview repeatedly characterizes itself as a diversified FinTech services company that integrates financial education, blockchain-related activities, wellness product manufacturing, and an early-stage online trading platform. For holders and prospective analysts of INVUP preferred shares, these disclosures indicate that the underlying issuer is exposed to multiple sectors: financial education and network marketing, digital asset mining, wellness manufacturing, and retail brokerage technology.

Investview’s public reports also discuss share repurchase programs for its common stock and capital allocation decisions, which may be relevant for understanding the issuer’s approach to capital structure and equity management. For example, the company has announced stock repurchase programs authorizing the buyback of a specified aggregate value of its common stock and has disclosed private and open-market repurchases that reduced the number of common shares outstanding. While these initiatives relate directly to common equity, they can be part of the broader context in which preferred securities such as INVUP exist.

Regulatory and legal matters also feature in Investview’s disclosures. In January 2025, the company announced a settlement of a previously disclosed SEC inquiry related to a legacy program involving the sale/leaseback of high-performance server equipment used primarily for Bitcoin mining (the “Apex Program”). Under that settlement, the SEC concluded that the interests offered in connection with the Apex Program were unregistered investment contracts sold in violation of Sections 5(a) and 5(c) of the Securities Act of 1933, and the company agreed to pay a civil penalty and to cease and desist from further violations of those provisions.

In a Form 8-K dated January 5, 2026, Investview reported that the Polish Office of Competition and Consumer Protection (UOKiK) issued a formal administrative decision regarding the company’s iGenius operations in Poland. UOKiK determined that certain aspects of the iGenius business model, as conducted in Poland, violated Polish laws relating to unfair commercial practices, including laws prohibiting pyramid-style promotional schemes, and imposed an administrative fine and a cease-and-desist order. Investview disclosed that it does not agree with the conclusions, intends to appeal, and expects to continue operations in Poland in the normal course during the appeal while evaluating operational adjustments. The company also cautioned that an adverse final outcome, or similar actions by other regulators, could have a materially adverse impact on its business, financial condition, results of operations, or prospects, given the significance of iGenius to its overall operations.

These regulatory developments are important considerations for understanding issuer risk for securities tied to Investview, including INVUP. The company’s own disclosures note that adverse regulatory outcomes could require modification, suspension, or discontinuation of certain operations and could expose the company to fines or further proceedings in other jurisdictions.

Investview’s news releases also describe ongoing operational initiatives across its segments, including efforts to respond to macroeconomic headwinds affecting direct sales and home-based business sectors, adjustments to Bitcoin mining operations in response to halving events, network difficulty and power curtailments, and investments in production capacity and technology at Renu Labs. The company frequently emphasizes a long-term strategic transformation plan that integrates financial technology, blockchain mining, wellness manufacturing, and online brokerage capabilities.

Because INVUP is a preferred stock series of Investview, Inc., analysis of this security typically involves understanding the multi-segment nature of the issuer’s operations, its exposure to digital asset markets and regulatory actions, and its stated plans for growth and diversification. Investors often review the company’s SEC filings, including Forms 10-K, 10-Q, and 8-K, as well as its public news releases, to evaluate the stability and risk profile of the issuer that stands behind the preferred shares.

Key Business Segments Underlying INVUP

• Financial Education and Technology (iGenius) – Provides financial education, tools, content, and research, and delivers products and services involving financial education, digital assets and related technology through a network of independent distributors. This unit is significant to Investview’s revenues and has been the subject of regulatory scrutiny in Poland.
• Blockchain Technology and Crypto Mining (SAFETek) – Owns and operates digital asset technologies focused on Bitcoin mining and related infrastructure, and has reported production of Bitcoin and adjustments to operations in response to halving events, mining difficulty, and energy curtailments.
• Health, Beauty and Wellness Manufacturing (Renu Labs / myLife Wellness) – Contract developer and manufacturer of proprietary and non-proprietary skincare, personal care, hair care, cosmetic, pharmaceutical topical, and wellness products, with myLife Wellness serving as marketing and e-commerce platform and leveraging existing distribution channels.
• Brokerage and Financial Markets (Opencash) – Early-stage online trading broker-dealer platform intended to offer self-directed retail brokerage services, including mobile and web applications, built around a proprietary trading engine acquired in 2021.

INVUP and the Investview Capital Structure

While detailed terms of the INVESTVIEW INC PFD SER B preferred stock are not provided in the available materials, it is clear that INVUP is an equity security issued by Investview, Inc. The company’s disclosures about its operating segments, regulatory matters, and capital allocation policies provide context for assessing the issuer’s overall profile. Analysts and investors commonly consider how the performance and risk of each segment, as well as regulatory developments such as the UOKiK decision and the SEC Apex Program settlement, might influence the issuer’s ability to support its various securities, including preferred stock series.